Kanter J, Ataga KI, Bhasin N, Guarino S, et al. Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel. Ann Hematol 2024;103:1909-1917.
PMID: 38642304